|
|||||
|
|
||||||
© 2003 American Society for Clinical Oncology
Staging Reclassification Affects Breast Cancer SurvivalBreast Cancer Outcomes Unit, B.C. Cancer Agency and University of British Columbia, Victoria, British Columbia, Canada To the Editor: We read with interest the observation of the "Will Rogers" phenomenon described by Woodward et al1 in their institutional series of 1,350 patients with mainly node-positive breast cancer treated with anthracycline chemotherapy at the University of Texas M.D. Anderson Cancer Center. We have examined the effect of changes in the sixth edition of the 2003 American Joint Committee on Cancer (AJCC) staging system,2 in a population-based series of 12,125 patients with newly diagnosed breast cancer referred to one of four BC Cancer Agency Centres in British Columbia, Canada, from 1989 to 1997. Our observations confirm those of Woodward et al and demonstrate applicability to the general population of patients with breast cancer.
The 2003 AJCC staging classification changes dependent on the number of involved nodes had the most dramatic effect. Compared to the AJCC fifth edition classification, nodal stage in the 2003 version separates patients with nodal involvement more reliably into prognostic groups (Fig 1
AUTHORS DISCLOSURES OF POTENTIAL CONFLICTS OF INTEREST The authors indicated no potential conflicts of interest.
REFERENCES
1. Woodward WA, Strom EA, Tucker SL, et al: Changes in the 2003 American Joint Committee on Cancer staging for breast cancer dramatically affect stage-specific survival. J Clin Oncol 21:32443248, 2003
2. Singletary SE, Allred C, Ashley P, et al: Revision of the American Joint Committee on Cancer staging system for breast cancer. J Clin Oncol 20:36283636, 2002
This article has been cited by other articles:
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||
|
Copyright © 2003 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
|